Beijing Foyou Pharma CO.,LTD

SHSE:601089 Voorraadrapport

Marktkapitalisatie: CN¥7.5b

Beijing Foyou PharmaLTD Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Beijing Foyou PharmaLTD has a total shareholder equity of CN¥3.5B and total debt of CN¥65.2M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are CN¥4.5B and CN¥1.1B respectively. Beijing Foyou PharmaLTD's EBIT is CN¥479.8M making its interest coverage ratio -10.6. It has cash and short-term investments of CN¥2.3B.

Belangrijke informatie

1.9%

Verhouding schuld/eigen vermogen

CN¥65.23m

Schuld

Rente dekkingsratio-10.6x
ContantCN¥2.30b
AandelenCN¥3.47b
Totaal verplichtingenCN¥1.07b
Totaal activaCN¥4.54b

Recente financiële gezondheidsupdates

Recent updates

Does Beijing Foyou PharmaLTD (SHSE:601089) Have A Healthy Balance Sheet?

Sep 29
Does Beijing Foyou PharmaLTD (SHSE:601089) Have A Healthy Balance Sheet?

Investors Shouldn't Be Too Comfortable With Beijing Foyou PharmaLTD's (SHSE:601089) Earnings

Apr 08
Investors Shouldn't Be Too Comfortable With Beijing Foyou PharmaLTD's (SHSE:601089) Earnings

Analyse van de financiële positie

Kortlopende schulden: 601089's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥1.0B).

Langlopende schulden: 601089's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥50.4M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 601089 has more cash than its total debt.

Schuld verminderen: 601089's debt to equity ratio has reduced from 36.3% to 1.9% over the past 5 years.

Schuldendekking: 601089's debt is well covered by operating cash flow (968.6%).

Rentedekking: 601089 earns more interest than it pays, so coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven